In early stages, measles can easily go undetected, potentially putting your patients and your community at risk.

The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

The patient’s own doctors couldn’t agree on a cause. One said asthma. Another implicated her age, then 71. A third blamed ...

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...

We look forward to advancing development of nalbuphine ER in the hopes of providing relief for the significant unmet need for these chronic cough patients. Based on these results, we plan to ...

Viral infection has gripped Solukhumbu district. Number of patients suffering from viral fever, common cold and cough, asthma, pneumonia, headache, respiratory problems and diarrhea has been ...

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in patients with IPF and RCC ...

Sitopaladi Churna for cold and cough contains pure and natural Vanshalochan crystals extracted from Bamboo Read this article to know the benefits of sitopaladi churna for cold cough and sore throat ...

Dr. Duffy says asthma, reflux, post-nasal drip, and drugs like ACE inhibitors for blood pressure, cause the most coughs. GERD, or reflux, can cause coughing, although coughing can also cause GERD.

The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests ...